A rational guide to reducing fracture risk in dialysis patients
Related Experiment Video
Updated: Jun 14, 2026

Fracture Apparatus Design and Protocol Optimization for Closed-stabilized Fractures in Rodents
Published on: August 14, 2018
Nigel D Toussaint1, Grahame J Elder, Peter G Kerr
1Department of Nephrology, Monash Medical Centre and Monash University, Clayton, Vic., Australia. nigel.toussaint@med.monash.edu.au
Insights
Fracture risk is higher in chronic kidney disease (CKD) patients, particularly those on dialysis (CKD-5D). This review examines fracture risks and management strategies specific to CKD-5D patients.
Area of Science:
- Nephrology
- Orthopedics
- Gerontology
Background:
- Fracture risk is elevated in chronic kidney disease (CKD) patients, especially those on dialysis (CKD-5D).
- Fractures in CKD-5D significantly increase morbidity and mortality.
- The aging dialysis population exacerbates the burden of fracture-related disease.
Purpose of the Study:
- To review the incidence, risk factors, and management of fractures in CKD-5D patients.
- To highlight the distinct fracture risks in CKD-5D patients compared to the general population.
- To provide recommendations for fracture risk reduction strategies in this population.
Main Methods:
- Literature review of available evidence on fractures in CKD-5D.
- Analysis of distinct risk factors, including CKD-mineral and bone disorder.
- Evaluation of diagnostic tools and therapeutic interventions for fracture risk in dialysis patients.
Main Results:
- Fracture risk is not directly comparable to the general population; standard osteoporosis tools may be less effective.
- Dual-energy X-ray absorptiometry is often not helpful for bone density measurement in CKD-5D.
- Therapeutic interventions for non-uremic populations are not always applicable to dialysis patients.
Conclusions:
- Management of bone fractures in CKD-5D requires specialized approaches distinct from the general population.
- CKD-mineral and bone disorder significantly contributes to increased fracture risk.
- Further research and tailored strategies are needed to effectively reduce fracture risk in CKD-5D.
Abstract:
Extrapolation of evidence-based management of disorders in the general population to patients with chronic kidney disease (CKD) is not always appropriate, and the prevention of bone fracture and reduction of fracture risk in CKD stages 3-5 is one example. Compared to the general population, fracture risk is greater in CKD patients, especially those on dialysis (CKD-5D). Fractures in CKD-5D are associated with a marked increase in morbidity and mortality and with an aging dialysis population the burden of disease caused by fracture is likely to increase. Patients with CKD-5D have distinct risks for fracture, as well as sharing risks identified in the general population. The development of the CKD mineral and bone disorder constitutes a significant cause for these differences. Literature addressing the determination of fracture risk and the efficacy of treatments to reduce fracture in patients on dialysis is limited. While some tools used for the diagnosis and monitoring of osteoporosis are applicable to patients on dialysis, bone mineral density measurement by dual-energy X-ray absorptiometry is generally not helpful and therapeutic interventions that reduce fracture risk in the nonuremic population cannot be generalized to patients on dialysis. This review outlines available evidence on the incidence, risk factors, and management of fractures in CKD-5D with recommendations for strategies to reduce fracture risk.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Peritoneal Dialysis III: Nursing Management
